Massachusetts Governor, Senate President, Speaker of the House, Leaders of Legislature, Medicine, and Advocacy Lead the Nation in the Fight Against Prostate Cancer

AdMeTech Foundation’s 15th Annual Prostate Cancer Awareness Day Highlights Massachusetts Model of National Leadership in Public Awareness, Medical Education, Research, Clinical Care and Equity

BOSTON,MA / ACCESSWIRE / March 27, 2024 / AdMeTech Foundation presents the 15th Annual Prostate Cancer Awareness Day. Senate President Pro Tempore William Brownsberger and Representative Gerry Cassidy are hosting this event. AdMeTech Foundation’s President Faina Shtern, M.D., and Thomas Satham, Director of Operations and Health Policy, serve as Masters of Ceremony.

This event has brought together Governor Maura Healey, Senate President Karen Spilka, Speaker of the House Ronald Mariano, Senate Majority Leader Cynthia Creem, Senate Majority Whip Mike Rush, Senator Pavel Payano, Representative Bud Williams, Chair of the Joint Committee on Racial Equity, Civil Rights and Inclusion and Chair of the Black and Latino Caucus, Representatives Carlos Gonzalez and Russell Holmes, Past Chairs of the Black and Latino Caucus, Representative Marjorie Decker, Chair of the Public Health Committee, and leaders of medicine, advocacy and community organizations.

15th Annual Prostate Cancer Awareness Day will honor the memory of two prostate cancer survivors – Representative Stephen Kulik and Mr. Naakh Vysoky. Representative Kulik served as a Host of this event and was a key state’s champion in the fight against prostate cancer between 2009 and his retirement in 2019. Mr. Vysoky was a lifelong warrior for the underprivileged – the elderly, the ethnic and racial minorities, and the immigrants; his work was recognized by the U.S. Congress and multiple Boston organizations.

Prostate cancer, striking one in eight men, is the most common male malignancy and the second most common cause of cancer deaths in men. Prostate cancer is a leading health disparity, causing more than two times higher mortality in Black men compared to White men. Elected officials will address prostate cancer as a public health priority for all men and a leading disparity in men with Black, Hispanic and Latino heritage, who are at higher risk of delayed diagnosis, poor quality of clinical care and death.

Advocates and prostate cancer survivors will discuss the impact of prostate cancer on men, their families and communities.

Leaders of medicine will review cutting-edge advances in clinical care and research, transforming screening, diagnosis and treatment, improving survival and reducing health disparities. Prostate cancer experts from AdMeTech Foundation, Mass General Brigham, UMass Memorial Health, and Beth Israel Lahey Health will invite Massachusetts men aged 40 and older to take part in the Prostate Cancer Equity Program. This groundbreaking program expedites access to the latest advances in patient care and supports men at every step of their medical journey. Supporting organizations include Massachusetts’ NAACP Branches and Latino Health Insurance Program, mobilizing the participation of Black, Hispanic and Latino men.

Annual Prostate Cancer Awareness Day has been critical for setting up a historic precedent by the Massachusetts General Court in recognizing prostate cancer as a public health priority and a leading health disparity since 2011. This event and the Prostate Cancer Equity Program are integral components of the broader state-wide prostate cancer program, which established a Massachusetts model of national and global leadership in public awareness, medical education, research and reducing health disparities since 2013.

The event sponsors include Lantheus, Astellas, Blue Earth Diagnostics, and Johnson and Johnson.

AdMeTech Foundation organized this event in cooperation with the Prostate Cancer Action Council, including the American Cancer Society Cancer Action Network, Center for Elimination of Health and Social Inequities and Disparities, Community Health Awareness Network Grows Equity, the Latino Health Insurance Program, Massachusetts Prostate Cancer Coalition, Men of Color Health Awareness, NAACP Branches, and Independent “Blue Ribbon” Expert Panel, consisting of the experts in clinical care and research.

WHEN: Thursday, March 28, 2024, 10 a.m. – 2 p.m.

WHERE: Virtual Event. Join the event by using this link:

https://www.facebook.com/manogram/

WHO: Governor Maura Healey

Senate President Karen Spilka

Speaker of the House Ronald Mariano

Senate Majority Leader Cynthia Creem

Senate President Pro Tempore William Brownsberger

Senate Majority Whip Mike Rush

Senator Pavel Payano

Representative Gerry Cassidy, Chair, Joint Committee on Veteran and Federal Affairs

Representative Carlos González, Chair, Public Safety and Homeland Security Committee

Representative Bud Williams, Chair, Joint Committee on Racial Equity, Civil Rights, and Inclusion; and Chair, Massachusetts Legislative Black and Latino Caucus

Thomas Satham, Director, Operations and Health Policy, AdMeTech Foundation

Faina Shtern, M.D., President and CEO, AdMeTech Foundation

Milagros Abreu, M.D., MPH, Founder, President, and CEO, Latino Health Insurance Program

Steve Bernard, Immediate Past President, Brockton Area Branch of NAACP

Juan Cofield, Prostate Cancer Survivor and President, Social Justice Foundation

Zane Crute, Secretary, NAACP New England Area Conference and Immediate Past President, Mystic Valley NAACP

Darren Duarte, Director of Communications and Spokesperson, Brockton Police, and Prostate Cancer Survivor

Rashaan Hall, President and CEO, Urban League

Jose Javier, Co-Founder, Metro Financial Solutions, and Prostate Cancer Advocate

Leona Martin, Member, Brockton Area Branch NAACP

Kenneth Reeves, President, Cambridge NAACP

Ronald Roberts, Prostate Cancer Survivor

Lamont Scott, Program Coordinator, Men of Color Health Awareness (MOCHA)

Dalton Skerritt, President, Center for Elimination of Health and Social Inequities and Disparities

Mitchell Sokoloff, M.D., Professor and Chair, Department of Urology, University of Massachusetts School of Medicine and UMass Memorial Medical Center

Quoc-Dien Trinh, M.D., MBA, Section Chief of Urology, Brigham and Women’s Faulkner Hospital; Co-Director; Dana-Farber/Brigham and Women’s Prostate Cancer Program; and Associate Professor of Surgery at Harvard Medical School

Shaun Wason, M.D., Faculty Member, Division of Urology and Associated Physician, Harvard Medical Faculty Physicians, Milton Center for Specialty Care and Needham Urology Associates, Beth Israel Deaconess Medical Center, Beth Israel Lahey Health, Harvard Medical School

About AdMeTech Foundation: A 501(c)(3) nonprofit organization, based in Boston, MA. AdMeTech Foundation established the Manogram® Project, providing national and international leadership for groundbreaking programs in research, education, awareness and advocacy. These programs have been expediting the advancement and implementation of precision, individualized approaches to screening, diagnosis and treatment of prostate cancer, and clinical care equity (www.admetech.org).

Contact Information

Nancy Petkunas
Vice President, Client Services, Michael P. Wasserman, Inc
npetkunas@mpwi.org
(508) 353-3357

SOURCE: AdMeTech Foundation

View the original press release on newswire.com.

Staff

Recent Posts

Laurel Bridge Software Advances Medical Imaging Workflow With New AI and Cloud Innovations at RSNA 2024

NEWARK, DE / ACCESSWIRE / November 22, 2024 / Laurel Bridge Software, a leader in…

2 hours ago

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

DENVER, CO / ACCESSWIRE / November 22, 2024 / Aytu BioPharma, Inc. (the "Company" or…

2 hours ago

Hemogenyx Pharmaceuticals PLC Announces Notice of Extraordinary General Meeting

Hemogenyx Pharmaceuticals plc("Hemogenyx Pharmaceuticals" or the "Company")Notice of Extraordinary General MeetingProposed Capital Reorganisation and New…

2 hours ago

Sunshine Biopharma Launches a New Generic Prescription Drug

FORT LAUDERDALE, FL / ACCESSWIRE / November 22, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the…

2 hours ago